1191 Immunotherapy with 4-1BBL-expressing iPSC-derived proliferating myeloid cells amplifies antigen-specific T cell infiltration in advanced melanoma

نویسندگان

چکیده

Among advanced melanomas, approximately 60% of the patients present with immunologic ignorance or intrinsic induction tumors need other therapeutic approaches to change an immunologically “cold tumor” “hot by attracting T cells into tumors. We have established immune cell therapy immortalized induced pluripotent stem–cell (iPSC)–derived proliferating myeloid (iPSC–pMCs). The benefits using iPSC−pMCs are infinite proliferative capacity and ease genetic modification. In this study, we introduced 4-1BBL gene iPSC–pMCs a background C57BL6 (iPSC–pMCs–41BBL). Cytokine array analysis was performed supernatants spleen that were cocultured withiPSC–pMCs iPSC–pMCs–41BBL. Multiple cytokines beneficial cancer immunotherapy upregulated. Peritoneal injections iPSC–pMCs–41BBL inhibited tumor growth peritoneally disseminated mouse melanoma prolonged survival mice than iPSC–pMCs. Furthermore, numbers antigen-specific CXCR6+CD8 significantly increased in tissues treated epitope peptide-pulsed These results suggest iPSC−pMCs−41BBL could activate antigen–specific promote their infiltration tissues. future clinical applications, plan use human allogenic treat patients. examined anticancer effects embryonic stem (ES) cell-derived pMC from 129Sv strain, which has different MHC class II compared mouse. Allogenic ES–pMC show suggested 4-1BBL-targeted strategies also work environments.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Regulatory T Cells and Myeloid-Derived Suppressor Cells in Patients with Peptic Ulcer and Gastric Cancer

Background: Regulatory T Cells (Tregs) and Myeloid-Derived Suppressor Cells (MDSCs) are two main regulatory cells modulating the immune responses in inflammation and cancer. Objective: To investigate and compare Tregs and MDSCs in peptic ulcer and gastric cancer. Methods: Patients with dyspepsia were selected and divided into three groups of non-ulcer dyspepsia (NUD, n=22), peptic ulcer disease...

متن کامل

Human melanoma metastases demonstrate nonstochastic site-specific antigen heterogeneity that correlates with T-cell infiltration.

PURPOSE Metastasis heterogeneity presents a significant obstacle to the development of targeted cancer therapeutics. In this study, we sought to establish from a large series of human melanoma metastases whether there exists a determined pattern in tumor cellular heterogeneity that may guide the development of future targeted immunotherapies. EXPERIMENTAL DESIGN From a cohort of 1,514 patient...

متن کامل

Monocytic myeloid-derived suppressor cells in advanced melanoma patients

The percentage of circulating CD14+CD11b+HLA-DR-/low myeloid-derived suppressor cells (MDSCs) inversely correlates with survival among advanced melanoma patients. High levels of MDSCs are associated with the absence of T lymphocytes specific for melanoma-derived antigens, implying a causal and clinically relevant interaction between these cell subsets. MDSCs might therefore represent prognostic...

متن کامل

Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells.

PURPOSE To analyze the prognostic relevance and relative impact of circulating myeloid-derived suppressor cells (MDSC) and regulatory T cells (Treg) compared with functional tumor antigen-specific T cells in patients with melanoma with distant metastasis. EXPERIMENTAL DESIGN The percentage of CD14(+)CD11b(+)HLA-DR(-/low) MDSCs, CD4(+)CD25(+)FoxP3(+) Tregs, and the presence of NY-ESO-1- or Mel...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Investigative Dermatology

سال: 2023

ISSN: ['1523-1747', '0022-202X']

DOI: https://doi.org/10.1016/j.jid.2023.03.1205